Novilytic operates as a company specialized in biochemistry analytics, focusing on safeguarding life-preserving medications and medical equipment. The company has garnered support through a portfolio of over 25 patents and strategic partnerships with a $2B Analytical Instrument Co., 2 Pharmaceutical Consortiums, and 2 Med & Analytical Universities. It leverages the expertise of 5 Ph.D. Chemists and Engineers to solidify its intellectual property. The business strategy includes expanding the team to effectively address customer, market, and regulatory requirements.